Ana Flávia Spadaccini Silva de Oliveira

Ana Flávia Spadaccini Silva de Oliveira

Auto-generated profile, based on publicly available information

Ana Flávia Spadaccini Silva de Oliveira

UNIFIO University Center, Ourinhos, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista Brasileira de Medicina do Esporte
Verified
Journal Article
Open access
AOAna Flávia Spadaccini Silva de Oliveira
Ana Flávia Spadaccini Silva de Oliveira
JSJéssica Lúcio da Silva
Jéssica Lúcio da Silva
CCCarlos Augusto Camillo
Carlos Augusto Camillo
RARodrigo Andraus
Rodrigo Andraus
LMLuciana Prado Maia
Luciana Prado Maia
Photobiomodulation (PBM) appears to limit exercise-induced muscle damage, improve biochemical and functional recovery, and reduce inflammation and oxidative stress. This systematic review aimed to evaluate the effectiveness of photobiomodulation (PBM) in skeletal muscle recovery after exercise, addressing the different types of lasers and parameters used. Randomized clinical trials (RCTs) comparing the effects of PBM were included. The primary outcome evaluated was performance, and the secondary was inflammatory marker expression. The searches were conducted in March 2021. Fifteen RCTs that met the inclusion criteria were included. There was significant variability regarding the doses and wavelengths used, as well as in the types of lasers. However, in most studies, PBM promoted improvement of maximum voluntary contraction, better oxygen consumption, increased time to achieve exhaustion and fatigue, and decreased creatine kinase (CK), oxidative stress, and fatigue markers, mainly when used before exercise. Photobiomodulation applied before exercise, regardless of variations in doses and wavelengths, improves muscle performance and decreases levels of inflammation and fatigue markers. Evidence level II; Systematic review of level II studies.

5 February 2026 in Lasers in Medical Science
Verified
Journal Article
Open access
PDF file
ASAna Flávia Spadaccini Silva-De-Oliveira
Ana Flávia Spadaccini Silva-De-Oliveira
JSJéssica Lúcio da Silva
Jéssica Lúcio da Silva
NSNathalia Thalitha Bernardes Dos Santos
Nathalia Thalitha Bernardes Dos Santos
RARodrigo Andraus
Rodrigo Andraus
RPRegina Célia Poli-Frederico
Regina Célia Poli-Frederico
LMLuciana Prado Maia
Luciana Prado Maia
Purpose: This study aimed to evaluate the effects of laser photobiomodulation therapy (LPT) on muscle cells subjected to oxidative stress. The primary objective was to determine whether LPT could preserve cell viability and modulate the expression of genes associated with muscle regeneration, specifically MyoD and myogenin , as well as the pro-inflammatory cytokine IL-6. Methods: C2C12 myoblasts were cultured and exposed to oxidative stress using hydrogen peroxide (H₂O₂) at a concentration of 50 µM for 1 h. Cells were then irradiated with LPT at wavelengths of 660–808 nm with fluences of 3, 5, and 10 J, applied either before (PRE-OS) or after (POST-OS) oxidative stress induction. Cell viability was assessed by the MTT assay, and gene expression was quantified using RT-qPCR. Results: Oxidative stress significantly reduced cell viability. LPT applied prior to OS with 660 nm (3 J) and 808 nm (3 and 10 J) attenuated this reduction. Notably, 10 J at 808 nm (PRE-OS) increased viability beyond control levels and markedly upregulated MyoD expression. Myogenin expression was also observed under 10 J PRE-OS conditions, while IL-6 expression was detected with 5 J at both wavelengths in PRE- and POST-OS groups. Conclusion: LPT demonstrated protective and regenerative effects on myoblasts under oxidative stress, preserving viability and enhancing regenerative gene expression. These findings support the potential of LPT as a therapeutic strategy for muscle injuries and disorders associated with oxidative stress.

12 January 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
RARodrigo Andraus
Rodrigo Andraus
AOAna Flávia Spadaccini Silva de Oliveira
Ana Flávia Spadaccini Silva de Oliveira
MLMário Celso Teixeira Lopes
Mário Celso Teixeira Lopes
DMDiego César Marques
Diego César Marques
VMVanessa Gabriela Gonzales Marques
Vanessa Gabriela Gonzales Marques
LMLuciana Prado Maia
Luciana Prado Maia
This study aimed to evaluate the effects of laser photobiomodulation (PBM) therapy in SaOs-2 osteosarcoma cells treated with zoledronic acid (ZA), a bisphosphonate, in vitro, mimicking a bisphosphonate-related osteonecrosis of the jaw (BRONJ) situation. Cells were treated with 100 μM ZA for 24 h and subjected to PBM using wavelengths of 660 nm and 808 nm at energy delivered of 1, 5, 10, and 20 J. After 24 h, metabolic activity, apoptosis, and BAX and BCL-2 gene expression were analyzed. Data were compared using one-way ANOVA followed by Tukey’s post hoc test (p < 0.05). ZA significantly reduced metabolic activity (p < 0.05), an effect attenuated by PBM at 808 nm with 1 J, while BCL-2 expression increased with 1 J at 660 nm and with 1 J and 20 J at 808 nm. However, PBM did not reverse ZA-induced apoptosis. In conclusion, PBM modulated the response of SaOs-2 osteoblastic cells treated with ZA in a wavelength- and dose-dependent manner. PBM at 808 nm and 1 J stimulated cell metabolic activity and upregulated BCL-2 expression, suggesting a potential protective effect against ZA-induced cytotoxicity.